EBS Emergent Biosolutions Inc
Emergent BioSolutions Inc is a biotechnology company operating in two divisions: biodefense and biosciences. The company focuses on countermeasures that address public health threats around hematology and oncology therapeutics.
$90.87 -3.86 (-4.08%)
As of 03/04/2021 16:00:02 EST IEX book CBOE book
Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Mid cap
Health Care
Drug Manufacturers—Specialty &
USA
USA
11/15/2006
53,300,000
676,831
$5,049,109,000
0.00%
SEC Edgar Online
10-Q
10-K
29089Q105
US29089Q1058
B1HJLW5
Common stocks
Mid cap
Health Care
Drug Manufacturers—Specialty &
USA
USA
11/15/2006
53,300,000
676,831
$5,049,109,000
0.00%
SEC Edgar Online
10-Q
10-K
29089Q105
US29089Q1058
B1HJLW5
Valuation (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
PB ratio:
PS ratio:
Return on equity:
Net income %:
16.55
3.48
3.25
21.09%
19.62%
3.48
3.25
21.09%
19.62%